These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2663519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
    Stief CG, Gilbert P, Wetterhauer U, Bähren W, Thon W, Altwein JE.
    Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
    [Abstract] [Full Text] [Related]

  • 3. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W, Lycklama à Nijeholt AA, Kropman RF, Vermeij P, Zwartendijk J.
    Eur Urol; 1994 May; 26(4):319-21. PubMed ID: 7713130
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug 08; 264(6):752-4. PubMed ID: 2374280
    [No Abstract] [Full Text] [Related]

  • 8. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ, de Meyer JM, de Sy WA, Claessens H.
    Paraplegia; 1986 Oct 08; 24(5):271-5. PubMed ID: 3774363
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risks of self-injection therapy for impotence.
    Millard RJ, Stricker PD, Lynch WJ, Dean TE, Murnaghan GF, Breslin FH.
    Med J Aust; 1996 Jul 15; 165(2):117-8. PubMed ID: 8692055
    [No Abstract] [Full Text] [Related]

  • 11. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y, Lidgi S, Moskovitz B, Levin RD.
    Harefuah; 1991 Oct 15; 121(7-8):223-5. PubMed ID: 1783307
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction].
    Steffens J, Postma HJ, Steffens L.
    Urologe A; 1988 Jan 15; 27(1):14-6. PubMed ID: 3363768
    [Abstract] [Full Text] [Related]

  • 14. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
    Valdevenito R, Melman A.
    Int J Impot Res; 1994 Jun 15; 6(2):81-91. PubMed ID: 7951702
    [Abstract] [Full Text] [Related]

  • 15. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H, Goldstein I, Krane RJ.
    Semin Urol; 1986 Nov 15; 4(4):236-8. PubMed ID: 3797893
    [No Abstract] [Full Text] [Related]

  • 16. Priapism: an avoidable complication of pharmacologically induced erection.
    Fouda A, Hassouna M, Beddoe E, Kalogeropoulos D, Binik YM, Elhilali MM.
    J Urol; 1989 Oct 15; 142(4):995-7. PubMed ID: 2795759
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.